TCON News and Press, TRACON Pharmaceuticals Inc. From 03/09/20

OSAKA, Japan and SAN DIEGO, March 09, 2020 (GLOBE NEWSWIRE) -- Santen Pharmaceutical Co., Ltd. (Head Office: Osaka; hereinafter, “Santen”) and TRACON Pharmaceuticals, Inc. (Head Office: San Diego, CA; hereinafter, “TRACON”) today announced the discontinuation of ...

The following slide deck was published by TRACON Pharmaceuticals, Inc. in conjunction with their 2019 Q4 earnings Read more ...

TRACON Pharmaceuticals Inc. (TCON) Q4 2019 Earnings Conference Call February 27, 2020 4:30 p.m. ET Company Participants Charles Theuer - President and CEO Scott Brown - Chief Accounting Officer Conference Call Participants Swapnil Malekar - Jefferies Bert Hazlett - BTIG ...

Tracon (NASDAQ: TCON ): Q4 GAAP EPS of -$1.25 beats by $0.52 . More news on: TRACON Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

SAN DIEGO, Feb. 27, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing a  product development platform to partner with ex-U.S....

SAN DIEGO, Feb. 20, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and wet age-related macular degeneration through our license to Santen Pha...

SAN DIEGO, Feb. 07, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, announced today that it has transferred its Nasdaq listing to the Nasdaq ...

Aethlon Medical (NASDAQ: AEMD )  -28%  on pricing equity offering. More news on: Aethlon Medical, Inc., aTyr Pharma, Inc., DURECT Corporation, Stocks on the move, , Read more ...

Cemtrex (NASDAQ: CETX ) +85%  after FY results . More news on: Cemtrex, Inc., Fluent, Inc., OrganiGram Holdings Inc., , Stocks on the move, Read more ...

Deals and Financings Ally Bridge Group, a Hong Kong-New York life science investment firm, announced it has led $140 million of investments in three new medical device companies, bringing its 18-month total to more than $500 million in private life science companies. ABG's latest investments...